Close Menu

A New Vector

Amit Nathwani at the University College London Cancer Institute and his colleagues tested a gene therapy approach for hemophilia B using an adenovirus-associated virus vector — one that's different from previously used adenovirus vectors — to deliver a corrected coagulation factor IX, or FIX, gene. As they report in the New England Journal of Medicine, Nathwani and his team performed a combined phase 1 and 2 clinical trial of their approach on six male patients with hemophilia B.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.